Zolbetuximab with chemotherapy for untreated claudin-18.2-positive HER2-negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinoma
Technology appraisal guidance
Reference number: TA1046
Published:
Evidence
Documents containing the evidence that was used to develop the recommendations.